BackBicara Therapeutics Common Stock Overview

Bicara Therapeutics Common Stock Goodwill

Bicara Therapeutics Common Stock's goodwill is $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Bicara Therapeutics Common Stock Goodwill History

Loading

Bicara Therapeutics Common Stock vs. peers: Goodwill Comparison

Loading

Bicara Therapeutics Common Stock Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bicara Therapeutics Common Stock (BCAX) FAQ

As of the most recent data (June 2026), BCAX shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCAX's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Bicara Therapeutics Common Stock is outperforming or lagging.

Tracking BCAX's goodwill over time shows whether Bicara Therapeutics Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Bicara Therapeutics Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.

Bicara Therapeutics Common Stock's goodwill is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.